Summer 2019 - Vaccines

WHO Issues New Flu Vaccine Composition Recommendations for 2019-2020 Season

The World Health Organization (WHO) advisory board issued its new recommendations on the composition of the influenza vaccines for use in the 2019-20 flu season in the Northern Hemisphere. According to the board, the egg-based quadrivalent vaccines should contain an A/Brisbane/ 02/2018 (H1N1)pdm09-like virus; an A/Kansas/14/2017 (H3N2)-like virus; a B/Colorado/06/2017-like virus (B/Victoria/ 2/87 lineage); and a B/Phuket/3073/2013- like virus (B/Yamagata/16/88 lineage). In addition, it recommended the influenza B virus component of trivalent vaccines be a B/Colorado/06/2017-like virus of the B/Victoria/2/87 lineage.

References

World Health Organization. Recommended Composition of Influenza Virus VaccinesforUseinthe2019-2020NorthernHemisphereInfluenzaSeason, Feb. 21, 2019. Accessed at www.who.int/influenza/vaccines/virus/ recommendations/2019_20_north/en.

BSTQ Staff
BioSupply Trends Quarterly [BSTQ] is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace. With timely and critical information, each themed issue covers topics ranging from product breakthroughs, industry insights and innovations, up-to-the-minute news on the latest clinical trials, accessibility, and service and safety concerns.